About Legalise Cannabis SA PartyAbout Legalise Cannabis SA Party The Legalise Cannabis SA Party was formed in mid 2021 and contested their first election in March 2022 with just 2 Legislative Council candidates.

Legalise Cannabis South Australia Party 7.

(a) The legalisation of medicinal cannabis in South Australia with reference to legal frameworks and approaches in other jurisdictions including implications for justice, health and the economy; and (b) Any other related matter.

I guess the interesting thing about cannabis and cannabis products is that degree of variability.

The Legislative Council and the House of Assembly have agreed to establish a Joint Committee to inquire into and report on: (a) The legalisation of medicinal cannabis in South Australia with reference to legal frameworks and approaches in other jurisdictions including implications for justice, health and the economy; and (b) Any other related matter.

Joint Committee on the Legalisation of Medicinal Cannabis

A wide range of medicinal cannabis products are being prescribed, including oils, oil solutions, dried cannabis flower, cannabis granulate and extracts.

It also listed chronic health effects of cannabis use such as:1 • selective impairment of cognitive functioning, which may be greater with prolonged use • development of a cannabis dependence syndrome and consequent withdrawal • exacerbation of schizophrenia in affected individuals and in those who are predisposed to experiencing psychosis, using THC containing cannabis may put them at an increased risk of cannabis-induced psychosis • an association between cannabis use disorder and schizophrenia among both males and females, but larger among males than females, especially among those aged 16–25.2,3,4 • airway injury, lung inflammation, and impaired pulmonary defence against infection • a higher prevalence of chronic and acute bronchitis • impairment in foetal development when cannabis is used during pregnancy • high level THC containing cannabis use for prolonged periods may result in the development of cannabis hyperemesis syndrome.

Reasons for rejection of section 18A Authority for medicinal cannabis Since April 2021 60 applications for s18A authority to prescribe medicinal cannabis have been refused: • The majority (55) of applications were refused because further information requested was not provided.

Late last year we published the Cannabis in Australia 2022 Report, which examined Australia's approach to medicinal cannabis, illicit cannabis and hemp in Australia.